Our Scientific Advisory Boards Contributing to Signant’s forward-looking strategy Contributing to Signant’s forward-looking strategy Our Scientific Advisory Boards (SABs), including Psychiatry, Neurology, and Internal Medicine, advise on future directions of the clinical trials market, technology, new products and other innovative trends to assist in Signant’s forward-looking strategy. Each SAB is led by a Signant Coordinator and is comprised of scientific and clinical experts who have made significant contributions to advancing the field and are committed to Signant’s mission. Psychiatry SAB Coordinator: Joan Busner, PhD Link to Profile → Charles B. Nemeroff, M.D., Ph.D. – SAB Chair Link to Profile → Jeffrey A. Lieberman, M.D. – SAB co-chair Link to Profile → Alan F. Schatzberg, M.D. – SAB member Link to Profile → Sanjay Johan Mathew, M.D. – SAB member Link to Profile → Philip D. Harvey, Ph.D. – SAB member Link to Profile → Madhukar Trivedi M.D. – SAB member Link to Profile →
Our Scientific Advisory Boards (SABs), including Psychiatry, Neurology, and Internal Medicine, advise on future directions of the clinical trials market, technology, new products and other innovative trends to assist in Signant’s forward-looking strategy. Each SAB is led by a Signant Coordinator and is comprised of scientific and clinical experts who have made significant contributions to advancing the field and are committed to Signant’s mission.
Coordinator: Joan Busner, PhD Link to Profile → Charles B. Nemeroff, M.D., Ph.D. – SAB Chair Link to Profile → Jeffrey A. Lieberman, M.D. – SAB co-chair Link to Profile → Alan F. Schatzberg, M.D. – SAB member Link to Profile → Sanjay Johan Mathew, M.D. – SAB member Link to Profile → Philip D. Harvey, Ph.D. – SAB member Link to Profile → Madhukar Trivedi M.D. – SAB member Link to Profile →